Vaccines · Special Issue

Personalized Cancer VaccinesBeyond Neoantigen Selection

Matching antigen, adjuvant, and immune context to move personalized vaccine research from promising targets toward durable anti-tumor immunity.

Open accessUnlimited reader access

Published by MDPIVaccines journal

Indexed in PubMedHigh research visibility

Mechanistic visualization · 59 seconds

From vaccination to intratumoral immune reactivation.

A conceptual journey through vaccine delivery, lymphatic trafficking, immune activation, vascular transit, tumor infiltration, immune suppression, and therapeutic reactivation.

Sound-designed visualization; no narration. Cellular events and sounds are illustrative rather than literal representations.

A whole-cycle view

Antigen selection is the beginning, not the finish line.

This Special Issue welcomes research that connects vaccine design with antigen presentation, T-cell response, tumor infiltration, immune memory, and the tumor microenvironment.

Personalized antigensVaccine platformsAdjuvants & innate immunityT-cell responsesCombination immunotherapyClinical translation

A direct path to the Guest Editor

Start with a question—or share work ready for consideration.

Use this portal for scope questions and preliminary review. A manuscript shared here is not a formal journal submission and does not enter peer review.

01

Ask a question

Best for questions about topic fit, scope, timing, or the submission process.

What happens next

A short, transparent path.

  1. 01
    Send

    Choose a question or research submission and provide the essentials.

  2. 02
    Review

    The Guest Editor reviews fit and the information you provide.

  3. 03
    Respond

    You receive guidance on scope or the appropriate official next step.

About the journal

Vaccines

An open access journal covering vaccine research and vaccination in the broadest sense, including cancer vaccines, emerging technologies, immune response, policy, and public health.

Visit the official journal website